u/spyapple

CRM generated $41.5B revenue, $7.5B net income, $15B OCF, and $6.6B Q1 FCF with a $50B buyback. At ~$190, the stock trades near historical low multiples despite 78% gross margins and strong cash conversion. Long CRM for potential re-rating and compounding cash flows; author sees 165%+ upside. Slower growth, lower-than-guided revenue, DCF terminal multiple too high, and macro/multiple compression.

CLX trades at 15.5x P/E and 12.8x EV/EBITDA vs historical averages of 30-45x and 18-24x respectively. Defensive staples with stable cash flow and a 4.7% dividend yield offer a favorable asymmetric risk/reward at current valuation. Re-rating toward historical multiples plus normalized FCF could generate ~200% upside over 4-5 years. Consumer spending weakness, further macro shocks, or prolonged supply chain/restructuring costs could push the stock lower short-term.

Accenture’s trailing EBITDA is $12.9B, EV is ~$77B, giving EV/EBITDA of 6.0x, while historical P/E averages 24–28x versus current ~11x. The disconnect between strong cash flows and low valuation creates a re-rating opportunity; even a partial reversion to historical multiples suggests >100% upside. Trade offers a value play on a high-quality consulting business trading at distressed levels, with buybacks and dividends providing a floor. Further tech sector headwinds, recession cutting consulting demand, or management guidance miss could delay re-rating or cause additional downside.